Logo image of CWAN

CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CWAN - US1851231068 - Common Stock

21.75 USD
+0.05 (+0.23%)
Last: 11/25/2025, 12:37:03 PM
Fundamental Rating

5

Overall CWAN gets a fundamental rating of 5 out of 10. We evaluated CWAN against 280 industry peers in the Software industry. CWAN has an average financial health and profitability rating. CWAN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CWAN had positive earnings in the past year.
CWAN had a positive operating cash flow in the past year.
CWAN had negative earnings in 4 of the past 5 years.
CWAN had a positive operating cash flow in 4 of the past 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

CWAN has a better Return On Assets (13.12%) than 90.36% of its industry peers.
The Return On Equity of CWAN (19.79%) is better than 87.14% of its industry peers.
CWAN's Return On Invested Capital of 0.01% is in line compared to the rest of the industry. CWAN outperforms 58.57% of its industry peers.
Industry RankSector Rank
ROA 13.12%
ROE 19.79%
ROIC 0.01%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

CWAN's Profit Margin of 61.25% is amongst the best of the industry. CWAN outperforms 95.36% of its industry peers.
In the last couple of years the Profit Margin of CWAN has grown nicely.
CWAN has a Operating Margin of 0.04%. This is comparable to the rest of the industry: CWAN outperforms 58.57% of its industry peers.
CWAN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 68.53%, CWAN is in line with its industry, outperforming 49.29% of the companies in the same industry.
CWAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.04%
PM (TTM) 61.25%
GM 68.53%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CWAN is destroying value.
The number of shares outstanding for CWAN has been increased compared to 1 year ago.
Compared to 5 years ago, CWAN has more shares outstanding
The debt/assets ratio for CWAN has been reduced compared to a year ago.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.16 indicates that CWAN is not in any danger for bankruptcy at the moment.
CWAN's Altman-Z score of 4.16 is fine compared to the rest of the industry. CWAN outperforms 67.86% of its industry peers.
CWAN has a debt to FCF ratio of 10.26. This is a negative value and a sign of low solvency as CWAN would need 10.26 years to pay back of all of its debts.
The Debt to FCF ratio of CWAN (10.26) is comparable to the rest of the industry.
CWAN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CWAN (0.42) is worse than 61.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 10.26
Altman-Z 4.16
ROIC/WACC0
WACC10.99%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.97 indicates that CWAN should not have too much problems paying its short term obligations.
CWAN has a Current ratio (1.97) which is in line with its industry peers.
A Quick Ratio of 1.97 indicates that CWAN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.97, CWAN is in line with its industry, outperforming 59.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

10

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.81% over the past year.
Measured over the past years, CWAN shows a very strong growth in Earnings Per Share. The EPS has been growing by 110.89% on average per year.
The Revenue has grown by 50.91% in the past year. This is a very strong growth!
The Revenue has been growing by 21.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%16.67%
Revenue 1Y (TTM)50.91%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%77.08%

3.2 Future

CWAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
The Revenue is expected to grow by 27.93% on average over the next years. This is a very strong growth
EPS Next Y25.49%
EPS Next 2Y27.59%
EPS Next 3Y26.62%
EPS Next 5Y28.57%
Revenue Next Year63.59%
Revenue Next 2Y45.94%
Revenue Next 3Y36.14%
Revenue Next 5Y27.93%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.83, the valuation of CWAN can be described as expensive.
CWAN's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 25.65. CWAN is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 29.69, which means the current valuation is very expensive for CWAN.
CWAN's Price/Forward Earnings ratio is in line with the industry average.
CWAN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.83
Fwd PE 29.69
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CWAN.
The rest of the industry has a similar Price/Free Cash Flow ratio as CWAN.
Industry RankSector Rank
P/FCF 77.82
EV/EBITDA 119.14
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

CWAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CWAN's earnings are expected to grow with 26.62% in the coming years.
PEG (NY)1.64
PEG (5Y)0.38
EPS Next 2Y27.59%
EPS Next 3Y26.62%

0

5. Dividend

5.1 Amount

No dividends for CWAN!.
Industry RankSector Rank
Dividend Yield N/A

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (11/25/2025, 12:37:03 PM)

21.75

+0.05 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners97.63%
Inst Owner Change1.86%
Ins Owners0.84%
Ins Owner Change2.14%
Market Cap6.37B
Revenue(TTM)640.38M
Net Income(TTM)392.23M
Analysts84.44
Price Target29.25 (34.48%)
Short Float %7.09%
Short Ratio3.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.09%
Min EPS beat(2)-6.22%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)1.93%
Min EPS beat(4)-6.22%
Max EPS beat(4)13.33%
EPS beat(8)5
Avg EPS beat(8)5.62%
EPS beat(12)9
Avg EPS beat(12)8.6%
EPS beat(16)12
Avg EPS beat(16)8.35%
Revenue beat(2)1
Avg Revenue beat(2)0.59%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.92%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)3.06%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.28%
PT rev (1m)-9.44%
PT rev (3m)-13.68%
EPS NQ rev (1m)0.62%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 41.83
Fwd PE 29.69
P/S 9.94
P/FCF 77.82
P/OCF 69.67
P/B 3.21
P/tB 19646.1
EV/EBITDA 119.14
EPS(TTM)0.52
EY2.39%
EPS(NY)0.73
Fwd EY3.37%
FCF(TTM)0.28
FCFY1.28%
OCF(TTM)0.31
OCFY1.44%
SpS2.19
BVpS6.77
TBVpS0
PEG (NY)1.64
PEG (5Y)0.38
Graham Number8.9
Profitability
Industry RankSector Rank
ROA 13.12%
ROE 19.79%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.03%
OM 0.04%
PM (TTM) 61.25%
GM 68.53%
FCFM 12.77%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-67.54%
ROICexgc growth 5Y-60.6%
ROICexc growth 3Y-68.91%
ROICexc growth 5Y-61.61%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 10.26
Debt/EBITDA 13.9
Cap/Depr 16.09%
Cap/Sales 1.49%
Interest Coverage 0.02
Cash Conversion 152.85%
Profit Quality 20.85%
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z 4.16
F-Score4
WACC10.99%
ROIC/WACC0
Cap/Depr(3y)83.6%
Cap/Depr(5y)112.55%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%16.67%
EPS Next Y25.49%
EPS Next 2Y27.59%
EPS Next 3Y26.62%
EPS Next 5Y28.57%
Revenue 1Y (TTM)50.91%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%77.08%
Revenue Next Year63.59%
Revenue Next 2Y45.94%
Revenue Next 3Y36.14%
Revenue Next 5Y27.93%
EBIT growth 1Y-97.99%
EBIT growth 3Y-24.56%
EBIT growth 5Y-21.29%
EBIT Next Year71.55%
EBIT Next 3Y43.29%
EBIT Next 5Y36.03%
FCF growth 1Y12.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.14%
OCF growth 3Y180.71%
OCF growth 5YN/A

CLEARWATER ANALYTICS HDS-A / CWAN FAQ

What is the ChartMill fundamental rating of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CWAN.


What is the valuation status of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a valuation rating of 2 / 10 to CLEARWATER ANALYTICS HDS-A (CWAN). This can be considered as Overvalued.


What is the profitability of CWAN stock?

CLEARWATER ANALYTICS HDS-A (CWAN) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

The Price/Earnings (PE) ratio for CLEARWATER ANALYTICS HDS-A (CWAN) is 41.83 and the Price/Book (PB) ratio is 3.21.


What is the financial health of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

The financial health rating of CLEARWATER ANALYTICS HDS-A (CWAN) is 4 / 10.